What type of study is this?

September 12, 2025CureusOpen Access

Effectiveness of Telemedicine and Electronic Call Reminder and Health Education Trial (TECARE Trial) for Type 2 Diabetes Mellitus: A Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Telemedicine interventions significantly reduced HbA1c levels from 7.3% to 6.7% in patients with type 2 diabetes.
Participants receiving telemedicine support experienced notable improvements in fasting and postprandial blood glucose levels.
Randomized controlled trial conducted with 200 participants assessed the impact of telemedicine on health outcomes.
Findings indicate the potential efficacy of telemedicine in managing type 2 diabetes within community health settings.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized controlled trial showed telemedicine enhances glycemic control and medication adherence in T2DM patients, suggesting wider community application.

Cite This Study

Chellaiyan et al. (2025) studied this question.

synapsesocial.com/papers/68d44c5531b076d99fa5613e https://doi.org/10.7759/cureus.91996

View Full Paper

Ask AI

Bookmark

Implication

Randomized controlled trial showed telemedicine enhances glycemic control and medication adherence in T2DM patients, suggesting wider community application.

Effectiveness of Telemedicine and Electronic Call Reminder and Health Education Trial (TECARE Trial) for Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Key Points

Discussion

Implication

Cite This Study

Effectiveness of Telemedicine and Electronic Call Reminder and Health Education Trial (TECARE Trial) for Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider